Gain Therapeutics Inc (GANX)
2.58
-0.11
(-4.09%)
USD |
NASDAQ |
May 17, 16:00
2.58
0.00 (0.00%)
After-Hours: 20:00
Gain Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | -9.31K% |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | -5.35K% |
March 31, 2022 | -7.27K% |
December 31, 2021 | -7.45K% |
September 30, 2021 | -17.05K% |
Date | Value |
---|---|
June 30, 2021 | -3.99K% |
March 31, 2021 | -46.51K% |
December 31, 2020 | -18.12K% |
September 30, 2020 | -11.86K% |
June 30, 2020 | -8.53K% |
March 31, 2020 | -8.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-46.51K%
Minimum
Mar 2021
-3.99K%
Maximum
Jun 2021
-13.11K%
Average
-8.76K%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
Eli Lilly and Co | 25.58% |
Alpine Immune Sciences Inc | -254.8% |
Outlook Therapeutics Inc | -- |
OptiNose Inc | -94.54% |
Greenwich LifeSciences Inc | -- |